If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

DICE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.30%

Insider Buying (Last 12 Months): $70,099,252.21

Insider Selling (Last 12 Months): $305,545.00

DICE Therapeutics Insider Trading History Chart

DICE Therapeutics Share Price & Price History

^$28.65

▼ -0.02 (-0.07%)

As of 03/31/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

DICE Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/29/2023	Ra Capital Management, L.P.	Director	Buy	66,369	$29.38	$1,949,921.22	6,874,208
3/28/2023	John R Jacobsen	Insider	Sell	500	$30.09	$15,045.00	184,506
3/27/2023	Ra Capital Management, L.P.	Director	Buy	151,132	$27.48	$4,153,107.36	6,561,060
3/23/2023	Ra Capital Management, L.P.	Director	Buy	155,089	$26.67	$4,136,223.63	6,217,593
3/17/2023	James Paul Scopa	Director	Sell	10,000	$29.05	$290,500.00	23,719
10/17/2022	Ra Capital Management, L.P.	Director	Buy	1,640,000	$36.50	$59,860,000.00	6,848,911

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for DICE Therapeutics (NASDAQ:DICE)

91.51% of DICE Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

DICE Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/31/2023	Metropolitan Life Insurance Co. NY	2,223	$69K	0.0%	+20.3%	0.005%
3/23/2023	MetLife Investment Management LLC	18,851	$0.59M	0.0%	+18.4%	0.040%
2/28/2023	Voya Investment Management LLC	29,293	$0.91M	0.0%	+161.1%	0.061%
2/16/2023	Alliancebernstein L.P.	26,900	$0.84M	0.0%	+3.1%	0.056%
2/15/2023	Metropolitan Life Insurance Co NY	2,223	$69K	0.0%	+20.3%	0.005%
2/15/2023	MetLife Investment Management LLC	18,851	$0.59M	0.0%	+18.4%	0.040%
2/15/2023	Jane Street Group LLC	16,118	$0.50M	0.0%	-205.3%	0.034%
2/15/2023	State of Wisconsin Investment Board	29,563	$0.92M	0.0%	N/A	0.062%
2/15/2023	SVB Financial Group	42,358	$1.32M	3.6%	N/A	0.089%
2/15/2023	Samsara BioCapital LLC	202,773	$6.33M	1.4%	-20.0%	0.425%
2/15/2023	Soleus Capital Management L.P.	173,447	$5.41M	0.8%	-67.6%	0.364%
2/15/2023	Squarepoint Ops LLC	46,079	$1.44M	0.0%	N/A	0.097%
2/15/2023	Legal & General Group Plc	14,338	$0.45M	0.0%	+182.1%	0.030%
2/15/2023	Millennium Management LLC	210,312	$6.56M	0.0%	-9.2%	0.441%
2/15/2023	Morgan Stanley	84,025	$2.62M	0.0%	+120.8%	0.176%
2/15/2023	EAM Global Investors LLC	36,420	$1.14M	0.3%	N/A	0.076%
2/15/2023	EAM Investors LLC	53,408	$1.67M	0.3%	N/A	0.112%
2/15/2023	Alkeon Capital Management LLC	1,038,125	$32.39M	0.1%	N/A	2.178%
2/15/2023	ArrowMark Colorado Holdings LLC	414,831	$12.94M	0.2%	-34.3%	0.870%
2/15/2023	Avoro Capital Advisors LLC	2,525,555	$78.80M	1.2%	+134.9%	5.298%
2/15/2023	Braidwell LP	839,075	$26.18M	0.9%	N/A	1.760%
2/14/2023	RA Capital Management L.P.	6,848,911	$213.69M	4.3%	+31.5%	14.367%
2/14/2023	VR Adviser LLC	819,000	$25.55M	4.1%	+7.1%	1.718%
2/14/2023	Price T Rowe Associates Inc. MD	3,219,960	$100.46M	0.0%	+26.1%	6.755%
2/14/2023	Amundi	2,993	$88K	0.0%	N/A	0.006%
2/14/2023	Two Sigma Investments LP	78,590	$2.45M	0.0%	N/A	0.165%
2/14/2023	Driehaus Capital Management LLC	1,953,706	$60.96M	0.9%	-0.9%	4.098%
2/13/2023	Charles Schwab Investment Management Inc.	253,277	$7.90M	0.0%	+34.2%	0.531%
2/13/2023	Deutsche Bank AG	17,136	$0.54M	0.0%	+48.6%	0.036%
2/13/2023	Barclays PLC	13,137	$0.41M	0.0%	+120.6%	0.028%
2/13/2023	Renaissance Technologies LLC	121,300	$3.79M	0.0%	N/A	0.254%
2/13/2023	The Manufacturers Life Insurance Company	55,309	$1.72M	0.0%	+4.3%	0.116%
2/13/2023	Sands Capital Ventures LLC	2,748,970	$85.77M	23.5%	-12.7%	5.767%
2/13/2023	Credit Suisse AG	26,395	$0.82M	0.0%	+193.4%	0.055%
2/13/2023	Geode Capital Management LLC	666,826	$20.80M	0.0%	+37.6%	1.399%
2/13/2023	American Century Companies Inc.	12,369	$0.39M	0.0%	N/A	0.026%
2/13/2023	GSA Capital Partners LLP	12,637	$0.39M	0.0%	N/A	0.027%
2/13/2023	JPMorgan Chase & Co.	37,582	$1.17M	0.0%	-91.3%	0.079%
2/10/2023	Bank of America Corp DE	30,078	$0.94M	0.0%	+82.7%	0.063%
2/10/2023	American International Group Inc.	16,742	$0.52M	0.0%	+24.2%	0.035%
2/10/2023	Amalgamated Bank	4,653	$0.15M	0.0%	+29.4%	0.010%
2/10/2023	Sei Investments Co.	9,771	$0.31M	0.0%	N/A	0.020%
2/10/2023	Franklin Resources Inc.	336,358	$10.49M	0.0%	N/A	0.706%
2/10/2023	Aigen Investment Management LP	8,160	$0.26M	0.0%	N/A	0.017%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	16,615	$0.52M	0.0%	+40.7%	0.035%
2/9/2023	Principal Financial Group Inc.	9,319	$0.29M	0.0%	N/A	0.020%
2/9/2023	Citigroup Inc.	6,411	$0.20M	0.0%	+24.4%	0.013%
2/8/2023	UBS Group AG	9,086	$0.28M	0.0%	+7,287.0%	0.019%
2/8/2023	Swiss National Bank	72,800	$2.27M	0.0%	+223.6%	0.153%
2/8/2023	Arizona State Retirement System	8,515	$0.27M	0.0%	N/A	0.018%
2/7/2023	State Board of Administration of Florida Retirement System	9,540	$0.30M	0.0%	-32.2%	0.020%
2/7/2023	Fox Run Management L.L.C.	9,901	$0.31M	0.1%	N/A	0.021%
2/7/2023	TD Asset Management Inc	60,739	$1.90M	0.0%	+6.1%	0.127%
2/6/2023	New Leaf Venture Partners L.L.C.	371,693	$11.60M	8.4%	-33.2%	0.780%
2/2/2023	SG Americas Securities LLC	16,603	$0.52M	0.0%	N/A	0.035%
2/2/2023	OUP Management Co. LLC	268,346	$8.37M	13.7%	-50.0%	0.563%
2/2/2023	ProShare Advisors LLC	8,498	$0.27M	0.0%	N/A	0.018%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	4,614	$0.14M	0.0%	N/A	0.010%
2/1/2023	DekaBank Deutsche Girozentrale	5,000	$0.16M	0.0%	N/A	0.010%
1/30/2023	New York State Common Retirement Fund	22,648	$0.71M	0.0%	-10.9%	0.048%
12/8/2022	Bank of New York Mellon Corp	94,864	$1.92M	0.0%	+32.8%	0.199%
11/21/2022	California State Teachers Retirement System	19,433	$0.39M	0.0%	-4.0%	0.041%
11/16/2022	Balyasny Asset Management LLC	459,677	$9.32M	0.0%	+67.3%	0.964%
11/15/2022	Alliancebernstein L.P.	26,100	$0.53M	0.0%	+15.5%	0.055%
11/15/2022	State Street Corp	494,329	$10.03M	0.0%	+17.6%	1.037%
11/15/2022	Trexquant Investment LP	17,605	$0.36M	0.0%	-21.7%	0.037%
11/15/2022	Vanguard Group Inc.	1,386,758	$28.12M	0.0%	+14.0%	2.909%
11/15/2022	Perceptive Advisors LLC	687,424	$13.94M	0.4%	-34.6%	1.442%
11/15/2022	Prelude Capital Management LLC	15,842	$0.32M	0.0%	+12.6%	0.033%
11/15/2022	Price T Rowe Associates Inc. MD	2,553,457	$51.79M	0.0%	+5.7%	5.356%
11/15/2022	Logos Global Management LP	1,085,251	$22.01M	2.7%	+10.1%	2.277%
11/15/2022	Ensign Peak Advisors Inc	11,177	$0.23M	0.0%	N/A	0.023%
11/15/2022	Bank of New York Mellon Corp	94,864	$1.92M	0.0%	+32.8%	0.199%
11/15/2022	BlackRock Inc.	1,906,691	$38.67M	0.0%	+10.9%	4.000%
11/14/2022	Nuveen Asset Management LLC	88,499	$1.80M	0.0%	-1.8%	0.186%
11/14/2022	VR Adviser LLC	764,979	$15.51M	2.3%	N/A	1.605%
11/10/2022	Tower Research Capital LLC TRC	1,238	$25K	0.0%	-23.2%	0.003%
11/8/2022	New York State Common Retirement Fund	25,431	$0.52M	0.0%	+27.2%	0.067%
11/3/2022	Barclays PLC	5,956	$0.12M	0.0%	+318.0%	0.016%
8/24/2022	Prelude Capital Management LLC	14,073	$0.22M	0.0%	-4.3%	0.037%
8/22/2022	Legal & General Group Plc	4,764	$74K	0.0%	+265.1%	0.012%
8/18/2022	Goldman Sachs Group Inc.	14,150	$0.22M	0.0%	+8.6%	0.037%
8/16/2022	Woodline Partners LP	636,987	$9.89M	0.2%	-1.9%	1.667%
8/16/2022	Price T Rowe Associates Inc. MD	2,414,624	$37.48M	0.0%	+12.6%	6.319%
8/16/2022	DAFNA Capital Management LLC	156,904	$2.44M	0.7%	+66.9%	0.411%
8/16/2022	Driehaus Capital Management LLC	2,230,538	$34.62M	0.6%	+5.0%	5.838%
8/15/2022	State Street Corp	420,223	$6.52M	0.0%	+86.0%	1.099%
8/15/2022	Citadel Advisors LLC	923,849	$14.34M	0.0%	+710.5%	2.417%
8/15/2022	Millennium Management LLC	179,620	$2.79M	0.0%	-36.2%	0.470%
8/13/2022	American International Group Inc.	13,289	$0.21M	0.0%	+92.2%	0.035%
8/12/2022	Northern Trust Corp	213,113	$3.31M	0.0%	+78.8%	0.557%
8/12/2022	Virtus ETF Advisers LLC	7,482	$0.12M	0.0%	+18.5%	0.020%
8/12/2022	Credit Suisse AG	8,857	$0.14M	0.0%	N/A	0.023%
8/12/2022	FMR LLC	1,910,328	$29.65M	0.0%	+460.0%	4.997%
8/12/2022	Rhumbline Advisers	40,022	$0.62M	0.0%	+174.3%	0.105%
8/11/2022	Trexquant Investment LP	22,497	$0.35M	0.0%	+39.9%	0.059%
8/9/2022	Swiss National Bank	22,500	$0.35M	0.0%	N/A	0.059%
8/5/2022	State Board of Administration of Florida Retirement System	14,080	$0.22M	0.0%	N/A	0.037%
8/5/2022	M&T Bank Corp	28,476	$0.44M	0.0%	N/A	0.074%
7/29/2022	SG Americas Securities LLC	8,429	$0.13M	0.0%	N/A	0.022%

Data available starting January 2016

DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVß1/aVß6 integrin for the treatment of idiopathic pulmonary fibrosis. In addition, the company focuses on immuno-oncology for antibody therapeutics. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Today's Range

Now: $28.65

$28.57

$30.64

50 Day Range

MA: $29.44

$26.05

$32.31

52 Week Range

Now: $28.65

$12.64

$45.99

Volume

639,168 shs

Average Volume

482,855 shs

Market Capitalization

$1.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.71

Who are the company insiders with the largest holdings of DICE Therapeutics?: DICE Therapeutics' top insider shareholders include:
Ra Capital Management, LP (Director)
John R Jacobsen (Insider)
James Paul Scopa (Director)
Learn More about top insider investors at DICE Therapeutics.
Who are the major institutional investors of DICE Therapeutics?: DICE Therapeutics' top institutional investors include:
RA Capital Management L.P. — 14.37%
Price T Rowe Associates Inc. MD — 6.75%
Sands Capital Ventures LLC — 5.77%
Avoro Capital Advisors LLC — 5.30%
Driehaus Capital Management LLC — 4.10%
Alkeon Capital Management LLC — 2.18%
Learn More about top institutional investors of DICE Therapeutics stock.
Which major investors are selling DICE Therapeutics stock?: Within the last quarter, DICE stock was sold by these institutional investors:
Sands Capital Ventures LLC
JPMorgan Chase & Co.
Soleus Capital Management L.P.
OUP Management Co. LLC
ArrowMark Colorado Holdings LLC
New Leaf Venture Partners L.L.C.
Sphera Funds Management LTD.
Boothbay Fund Management LLC
Within the last year, company insiders that have sold DICE Therapeutics company stock include:
Ra Capital Management, LP (Director)
John R Jacobsen (Insider)
Learn More investors selling DICE Therapeutics stock.
Which major investors are buying DICE Therapeutics stock?: Within the last quarter, DICE stock was bought by institutional investors including:
RA Capital Management L.P.
Avoro Capital Advisors LLC
Alkeon Capital Management LLC
Braidwell LP
Price T Rowe Associates Inc. MD
Franklin Resources Inc.
Geode Capital Management LLC
Renaissance Technologies LLC

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

DICE Insider Trading

DICE Therapeutics Insider Trading History Chart

DICE Therapeutics Share Price & Price History

DICE Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for DICE Therapeutics (NASDAQ:DICE)

Institutional Buying and Selling by Quarter

DICE Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of DICE Therapeutics?

Who are the major institutional investors of DICE Therapeutics?

Which major investors are selling DICE Therapeutics stock?

Which major investors are buying DICE Therapeutics stock?